Shared conversation on NexusTrade
Biotech Stock INSP: Profitability Turnaround and Growth Analysis
Analysis of Inspire Medical Systems (INSP), a biotechnology stock that turned profitable, showing consistent growth in net income and revenue, with a market cap below $20 billion. Includes a deep research report and watchlist creation.
Aurora: Hello. Do you need help finding some new stocks for your watchlist? Maybe we can find stocks based on their Earnings Per Share or Volume?
User: What biotechnology stocks were unprofitable last year, are profitable this year, have increased their net income every quarter for the past 4 quarters, and have increased their revenue every year for the past 4 years? Filter to stocks with a market cap below $20 billion.
Aurora: Okay, I looked for biotechnology stocks that fit some very specific criteria: a market cap under $20 billion, a recent turnaround from unprofitability to profitability, and consistent growth in both quarterly net income (last 4 quarters) and annual revenue (last 4 years). It turns out that finding a company meeting *all* these conditions is quite rare! Only one stock matched everything: ### Biotechnology Stock Screener Results | Ticker | Market Cap (USD) | | :----- | :--------------- | | [INSP](https://nexustrade.io/stock/INSP) | $4,719,215,877 | This means that Inspire Medical Systems, Inc. (INSP) was the only biotechnology company under the $20 billion market cap threshold that demonstrated both a profitability turnaround (from negative net income in the second-to-last fiscal year to positive net income in the most recent fiscal year) *and* showed consistent sequential growth in revenue annually for the past four years *and* consistent sequential growth in net income quarterly for the past four quarters, based on the available data. **Pros:** * **Strong Financial Momentum:** The criteria used are quite demanding. Meeting them suggests INSP has shown impressive recent performance…
User: Do a deep research report on INSP. What is this stock?
Aurora: # Comprehensive Analysis of Inspire Medical Systems, Inc. (INSP) Stock Inspire Medical Systems, Inc. (NYSE: INSP) is a medical technology company specializing in minimally invasive solutions for obstructive sleep apnea (OSA). The company’s flagship product, the Inspire system, is an FDA-approved neurostimulation device that targets moderate to severe OSA patients who cannot tolerate continuous positive airway pressure (CPAP) therapy. As of April 29, 2025, INSP trades at $158.14 per share, reflecting a market capitalization of $4.47 billion. This report provides a detailed examination of INSP’s financial performance, market position, growth drivers, and future outlook. --- ## Company Overview and Technological Innovation ### The Inspire System: Addressing Unmet Clinical Needs Inspire Medical’s core innovation is the Inspire system, a hypoglossal nerve stimulator that maintains airway patency during sleep. Unlike CPAP machines, which require patients to wear masks, the Inspire device is surgically implanted and activated via a remote control. This solution caters to the estimated 20-30% of OSA patients who are non-compliant with CPAP therapy[2][6]. The system’s closed-loop technolog…
User: Summarize what INSP is in 4 bullets
Aurora: * **Medical Technology Company:** Inspire Medical Systems (INSP) develops and sells minimally invasive solutions for Obstructive Sleep Apnea (OSA). * **Flagship Product:** Their main product is the Inspire system, an FDA-approved implantable neurostimulation device that keeps the airway open during sleep. * **Target Market:** It's designed for moderate to severe OSA patients who cannot tolerate or get consistent benefit from CPAP therapy. * **Growth & Financials:** The company has shown strong revenue growth, recently achieved profitability, and is expanding its market presence both in the U.S. and internationally.
User: Create a watchlist with just INSP
Aurora: Okay, you want to create a watchlist focusing specifically on Inspire Medical Systems, Inc. This will help you track this medical technology company known for its innovative treatment for Obstructive Sleep Apnea. Here is the watchlist with INSP: